External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology ECP 2024
Roche and Genentech at

ECP 2024

September 07 - September 11
Florence, Italy
ecp.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:00 PM
Duration 1hr Florence, Italy
Interpretation of B cell malignancies using an ultrasensitive dual in situ hybridization (ISH) for kappa and lambda light chain restriction mRNA demonstrates high level of reproducibility between three sites
Bowdoin Su
Oncology | B Cell Lymphoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Analytic Concordance of a Novel pan-tumor HRD Signature Biomarker Between AVENIO Tumor Tissue CGP Kit V2 (AVENIO CGP) and FoundationOneCDx (F1CDx)
Jonathan Choi
Oncology | Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Characterizing Tumor Heterogeneity through Quantitative Pathology Features For Lung Cancer Patients’ Survival Prediction
Paolo Ocampo
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Analytical verification of the Roche HER2 (4B5) Assay to assess HER2-ultralow status in Breast Cancer
Paula Toro
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Analytical performance of a diagnostic immunohistochemical assay for MET protein (c-Met) in non-small cell lung cancer
Landon Inge
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Applicability of a Ki67 image analysis breast algorithm on gastro-intestinal and hepatopancreaticobiliary neuroendocrine neoplasms
Landon Inge
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florence, Italy
Breast Her-2 IHC assessment: pathologists’ concordance is excellent using the binary system (Negative/Positive) but poor using the three-tier system (Negative/Low/Positive). A study of 612 practitioners from 62 countries
Sarah Wedden
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.